Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
This trial is active, not recruiting.
|Condition||squamous cell carcinoma|
|Sponsor||University of Zurich|
|Collaborator||Leiden University Medical Center|
|Start date||November 2013|
|End date||January 2019|
|Trial size||100 participants|
|Trial identifier||NCT01976468, SCOPE-ITSCC metastases|
The investigators hypothesize that a low number of SCC in OTR will metastasize.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
organ transplant recipients
time frame: two years
Male or female participants at least 18 years old.
Inclusion criteria: - Organ-transplant recipients (OTR). - Histologically proven cutaneous invasive SCC at time of inclusion Exclusion criteria: - Lack of consent. - History of metastases of cutaneous SCC
|Official title||Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"|
|Principal investigator||Günther Hofbauer, Prof MD|
|Description||In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.|
Call for more information